Cite
HARVARD Citation
Drouin, E. et al. (n.d.). A novel human autoantigen, endothelial cell growth factor, is a target of T and B cell responses in patients with Lyme disease. Arthritis and rheumatism. 65 (1), pp. 186-196. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Drouin, E. et al. (n.d.). A novel human autoantigen, endothelial cell growth factor, is a target of T and B cell responses in patients with Lyme disease. Arthritis and rheumatism. 65 (1), pp. 186-196. [Online].